Esomeprazole placebo

DRUG3 trials

Sponsors

Takeda, Daewoong Pharmaceutical Co. LTD., Onconic Therapeutics Inc.

Conditions

Erosive Gastroesophageal Reflux DiseaseGERDGastroesophageal Reflux

Phase 2

Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

CompletedNCT02743949

TakedaGastroesophageal Reflux

Start: 2016-07-14End: 2018-10-12Updated: 2020-02-18

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

CompletedNCT03184324

Daewoong Pharmaceutical Co. LTD.Erosive Gastroesophageal Reflux Disease

Start: 2017-08-28End: 2018-04-18Updated: 2020-09-03

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

CompletedNCT04282954

Onconic Therapeutics Inc.GERD

Start: 2019-11-15End: 2020-12-11Updated: 2022-07-13